These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18164548)

  • 21. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.
    Wu F; Catano M; Echeverry R; Torre E; Haile WB; An J; Chen C; Cheng L; Nicholson A; Tong FC; Park J; Yepes M
    J Neurosci; 2014 Oct; 34(43):14219-32. PubMed ID: 25339736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
    Yi JS; Kim YH; Koh JY
    Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
    Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
    Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
    Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
    Bai X; Weitz JI; Gross PL
    Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.
    Kiprianova I; Schindowski K; von Bohlen und Halbach O; Krause S; Dono R; Schwaninger M; Unsicker K
    Exp Neurol; 2004 Oct; 189(2):252-60. PubMed ID: 15380477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model.
    Fisher JL; Mackie PS; Howard ML; Zhou H; Choong PF
    Clin Cancer Res; 2001 Jun; 7(6):1654-60. PubMed ID: 11410503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
    Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
    Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
    J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression changes of urokinase plasminogen activator and urokinase receptor in rat testes at postnatal stages.
    Huang DH; Zhao H; Tian YH; Li HG; Ding XF; Xiong CL
    Asian J Androl; 2007 Sep; 9(5):679-83. PubMed ID: 17712486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor.
    Nagase K; Kobayashi H; Yoshikawa E; Kurita N
    J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No role for interleukin-18 in acute murine stroke-induced brain injury.
    Wheeler RD; Boutin H; Touzani O; Luheshi GN; Takeda K; Rothwell NJ
    J Cereb Blood Flow Metab; 2003 May; 23(5):531-5. PubMed ID: 12771567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in the seminal plasma and sperm of fertile and oligoasthenozoospermia males].
    Wang L; Guan HT; Tian YH; Xiong CL
    Zhonghua Nan Ke Xue; 2006 Sep; 12(9):791-3. PubMed ID: 17009528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase receptor variants in tissue and body fluids.
    Høyer-Hansen G; Lund IK
    Adv Clin Chem; 2007; 44():65-102. PubMed ID: 17682340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
    Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transient focal cerebral ischemia in mice deficient in puma.
    Kuroki K; Virard I; Concannon CG; Engel T; Woods I; Taki W; Plesnila N; Henshall DC; Prehn JH
    Neurosci Lett; 2009 Feb; 451(3):237-40. PubMed ID: 19159665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting uPA/uPAR in prostate cancer.
    Li Y; Cozzi PJ
    Cancer Treat Rev; 2007 Oct; 33(6):521-7. PubMed ID: 17658220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.